Literature DB >> 22331054

Noninvasive imaging modalities and sudden cardiac arrest in the young: can they help distinguish subjects with a potentially life-threatening abnormality from normals?

Beth Feller Printz1.   

Abstract

Sudden cardiac arrest (SCA) in the young is always tragic, but fortunately it is an unusual event. When it does occur, it usually happens in active individuals, often while they are participating in physical activity. Depending on the population's characteristics, the most common causes of sudden cardiac arrest in these subjects are hypertrophic cardiomyopathy, congenital coronary abnormalities, arrhythmia in the presence of a structurally normal heart (ion channelopathies or abnormal conduction pathways), aortic rupture, and arrhythmogenic right-ventricular cardiomyopathy. Two-dimensional echocardiography (2-DE) has been proposed as a screening tool that can potentially detect four of these five causes of SCA, and many groups now sponsor community-based 2-DE SCA-screening programs. "Basic" 2-DE screening may include assessment of ventricular volumes, mass, and function; left atrial size; and cardiac and thoracic vascular (including coronary) anatomy. "Advanced" echocardiographic techniques, such as tissue Doppler and strain imaging, can help in diagnosis when the history, electrocardiogram (ECG), and/or standard 2-DE screening suggest there may be an abnormality, e.g., to help differentiate those with "athlete's heart" from hypertrophic or dilated cardiomyopathy. Cardiac magnetic resonance imaging or cardiac computed tomography can be added to increase diagnostic sensitivity and specificity in select cases when an abnormality is suggested during SCA screening. Test availability, cost, and ethical issues related to who to screen, as well as the detection of those with potential disease but low risk, must be balanced when deciding what tests to perform to assess for increased SCA risk.

Entities:  

Mesh:

Year:  2012        PMID: 22331054     DOI: 10.1007/s00246-012-0169-z

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  62 in total

1.  Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.

Authors:  Barry J Maron; Paul D Thompson; Michael J Ackerman; Gary Balady; Stuart Berger; David Cohen; Robert Dimeff; Pamela S Douglas; David W Glover; Adolph M Hutter; Michael D Krauss; Martin S Maron; Matthew J Mitten; William O Roberts; James C Puffer
Journal:  Circulation       Date:  2007-03-12       Impact factor: 29.690

2.  Ethnic differences in physiological cardiac adaptation to intense physical exercise in highly trained female athletes.

Authors:  J Rawlins; F Carre; G Kervio; M Papadakis; N Chandra; C Edwards; G P Whyte; S Sharma
Journal:  Circulation       Date:  2010-02-22       Impact factor: 29.690

3.  Two-dimensional strain analysis of the global and regional myocardial function for the differentiation of pathologic and physiologic left ventricular hypertrophy: a study in athletes and in patients with hypertrophic cardiomyopathy.

Authors:  T Butz; F van Buuren; K P Mellwig; C Langer; G Plehn; A Meissner; H J Trappe; D Horstkotte; L Faber
Journal:  Int J Cardiovasc Imaging       Date:  2010-07-10       Impact factor: 2.357

4.  Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.

Authors:  Carsten Rickers; Norbert M Wilke; Michael Jerosch-Herold; Susan A Casey; Prasad Panse; Neeta Panse; Jochen Weil; Andrey G Zenovich; Barry J Maron
Journal:  Circulation       Date:  2005-08-09       Impact factor: 29.690

5.  Two-dimensional echocardiographic methods for assessment of left atrial volume.

Authors:  Keiji Ujino; Marion E Barnes; Stephen S Cha; Andrew P Langins; Kent R Bailey; James B Seward; Teresa S M Tsang
Journal:  Am J Cardiol       Date:  2006-09-07       Impact factor: 2.778

6.  Significance of left atrial volume in patients < 20 years of age with hypertrophic cardiomyopathy.

Authors:  Shaji C Menon; Michael J Ackerman; Frank Cetta; Patrick W O'Leary; Benjamin W Eidem
Journal:  Am J Cardiol       Date:  2008-09-11       Impact factor: 2.778

7.  Screening for hypertrophic cardiomyopathy in young athletes.

Authors:  D Corrado; C Basso; M Schiavon; G Thiene
Journal:  N Engl J Med       Date:  1998-08-06       Impact factor: 91.245

Review 8.  Distinguishing hypertrophic cardiomyopathy from athlete's heart physiological remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening.

Authors:  B J Maron
Journal:  Br J Sports Med       Date:  2009-09       Impact factor: 13.800

9.  The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes.

Authors:  A Pelliccia; B J Maron; A Spataro; M A Proschan; P Spirito
Journal:  N Engl J Med       Date:  1991-01-31       Impact factor: 91.245

10.  In vivo detection of coronary artery anomalies in asymptomatic athletes by echocardiographic screening.

Authors:  P Zeppilli; A dello Russo; C Santini; V Palmieri; L Natale; A Giordano; A Frustaci
Journal:  Chest       Date:  1998-07       Impact factor: 9.410

View more
  1 in total

Review 1.  Global cerebral ischemia: synaptic and cognitive dysfunction.

Authors:  Jake T Neumann; Charles H Cohan; Kunjan R Dave; Clinton B Wright; Miguel A Perez-Pinzon
Journal:  Curr Drug Targets       Date:  2013-01-01       Impact factor: 3.465

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.